Certara, Inc. (CERT) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Certara, Inc. · Health Care · ref. ETF XLV · 50 calls · price $8.41
What the company does: Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific.
📈 Certara, Inc. (CERT) stock price
$8.41-22.6% over range
Aug 28, 25low $4.48 · high $13.6Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
29% recommend buying · 7 analysts
📊 JPI status : Certara, Inc. has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.
🎯 CERT price target & analyst consensus — price $8.41
The price target · all analysts combined (7 targets)
Highest target · 1 firm of 7$10+18.9%
Median target · of 7 targets$8-4.9%
Lowest target · 2 firms of 7$6-28.7%
Current price$8.41
Where these 7 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
229%
$9 ↔ $10
Below
571%
$6 ↔ $8
⭐ What the most reliable analysts say
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
The consensus · 7 ratings (last 6 months)
Strong Buy00%
Buy229%
Hold571%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 CERT price target all
All 50 calls, one by one, with our verdict on each firm.
→ See all 50 targets, analyst by analyst💡 The best analysts on CERT most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in CERT? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Certara, Inc.? The JPI assistant answers using our backtest data.
✅ Historical analyst reliability on CERT
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| UBS ↗ | 50% | -11.1% | 2 |
| Barclays ↗ | 25% | -16.5% | 8 |
| Credit Suisse | 0% | -14.9% | 5 |
| SVB Leerink | 0% | -15.5% | 2 |
| Piper Sandler ↗ | 0% | -17.8% | 2 |
| B of A Securities ↗ | 0% | -25.9% | 2 |
| Stephens & Co. ↗ | 0% | -26.7% | 3 |
| Keybanc ↗ | 0% | -41.1% | 4 |
📊 What $1,000 invested in Certara, Inc. would be worth › open the full page
In short — $1,000 invested in Certara, Inc. 10 years ago would be worth $175 today, i.e. -25%/yr on average. Best year: 2023 (+9%), worst: 2022 (-43%). Price performance, excluding dividends.
If I'd invested $1,000 in Certara, Inc.
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $595 | -40% |
| 3 years ago | $415 | -58% |
| 5 years ago | $198 | -80% |
Return by year (Certara, Inc.)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -24% | $763 (-24%) |
| 2025 | -22% | $595 (-40%) |
| 2024 | -36% | $379 (-62%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Certara, Inc.
Loading news…
📋 All analyst calls on CERT
Filtered on — · ✕ show all
■ Equal-Weight neutral · not a buy · 🎯$7.5
Price at call : $8.01 — gap to target -6%
Today : $8.41 — gap to target -11%
🎯 on CERT : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
Craig-Hallum ↗
May 12, 26
■ Hold neutral · not a buy · 🎯$8
Price at call : $4.79 — gap to target +67%
Today : $8.41 — gap to target -5%
🎯 on CERT : no call matured yet · 📊 on Health : 60.9% · +21.4% (23 calls)
in progress (365j)
matures : May 12, 27
matures : May 12, 27
BMO Capital ↗
May 12, 26
■ Market Perform neutral · not a buy · 🎯$6
Price at call : $4.79 — gap to target +25%
Today : $8.41 — gap to target -29%
🎯 on CERT : no call matured yet · 📊 on Health : 43.9% · -2.1% (66 calls)
in progress (365j)
matures : May 12, 27
matures : May 12, 27
■ Equal-Weight neutral · not a buy · 🎯$6.5
Price at call : $4.79 — gap to target +36%
Today : $8.41 — gap to target -23%
🎯 on CERT : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : May 12, 27
matures : May 12, 27
Stephens & Co. ↗
May 12, 26
▲ Overweight · 🎯$9
Price at call : $4.79 — upside +88%
Today : $8.41 — upside +7%
🎯 on CERT : 0% (2 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
in progress (365j)
matures : May 12, 27
matures : May 12, 27
Morgan Stanley ↗
May 12, 26
■ Equal-Weight neutral · not a buy · 🎯$10
Price at call : $5.09 — gap to target +96%
Today : $8.41 — gap to target +19%
🎯 on CERT : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : May 12, 27
matures : May 12, 27
■ Neutral neutral · not a buy · 🎯$6
Price at call : $5.09 — gap to target +18%
Today : $8.41 — gap to target -29%
🎯 on CERT : no call matured yet · 📊 on Health : 37.8% · -2.8% (82 calls)
in progress (365j)
matures : May 12, 27
matures : May 12, 27
▲ Overweight · 🎯$8
Price at call : $5.79 — upside +38%
Today : $8.41 — upside -5%
🎯 on CERT : 0% (4 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : Apr 13, 27
matures : Apr 13, 27
See the other 42 calls, newest to oldest
■ Equal-Weight neutral · not a buy · 🎯$8
Price at call : $7.06 — gap to target +13%
Today : $8.41 — gap to target -5%
🎯 on CERT : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Mar 6, 27
matures : Mar 6, 27
▲ Overweight · 🎯$8
Price at call : $7.05 — upside +13%
Today : $8.41 — upside -5%
🎯 on CERT : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Feb 27, 27
matures : Feb 27, 27
▲ Overweight · 🎯$12
Price at call : $9.67 — upside +24%
Today : $8.41 — upside +43%
🎯 on CERT : 0% (4 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : Jan 8, 27
matures : Jan 8, 27
Leerink Partners ↗
Jan 6, 26
▲ Outperform · 🎯$13
Price at call : $9.49 — upside +37%
Today : $8.41 — upside +55%
🎯 on CERT : no call matured yet · 📊 on Health : 50% · -5.3% (10 calls)
in progress (365j)
matures : Jan 6, 27
matures : Jan 6, 27
Morgan Stanley ↗
Dec 18, 25
■ Equal-Weight neutral · not a buy · 🎯$12
Price at call : $9.07 — gap to target +32%
Today : $8.41 — gap to target +43%
🎯 on CERT : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Dec 18, 26
matures : Dec 18, 26
▲ Overweight · 🎯$13
Price at call : $8.66 — upside +50%
Today : $8.41 — upside +55%
🎯 on CERT : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
Stephens & Co. ↗
Dec 12, 25
▲ Overweight · 🎯$12
Price at call : $8.58 — upside +40%
Today : $8.41 — upside +43%
🎯 on CERT : 0% (2 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
in progress (365j)
matures : Dec 12, 26
matures : Dec 12, 26
BMO Capital ↗
Nov 13, 25
■ Market Perform neutral · not a buy · 🎯$9
Price at call : $8.41 — gap to target +7%
Today : $8.41 — gap to target +7%
🎯 on CERT : no call matured yet · 📊 on Health : 43.9% · -2.1% (66 calls)
in progress (365j)
matures : Nov 13, 26
matures : Nov 13, 26
▲ Overweight · 🎯$14
Price at call : $8.62 — upside +62%
Today : $8.41 — upside +66%
🎯 on CERT : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
▲ Overweight · 🎯$16
Price at call : $13 — upside +23%
Today : $8.41 — upside +90%
🎯 on CERT : 0% (4 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : Oct 8, 26
matures : Oct 8, 26
▲ Overweight · 🎯$16
Price at call : $13.07 — upside +22%
Today : $8.41 — upside +90%
🎯 on CERT : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Oct 2, 26
matures : Oct 2, 26
Craig-Hallum ↗
Sep 29, 25
▲ Buy · 🎯$16
Price at call : $12.22 — upside +31%
Today : $8.41 — upside +90%
🎯 on CERT : no call matured yet · 📊 on Health : 60.9% · +21.4% (23 calls)
in progress (365j)
matures : Sep 29, 26
matures : Sep 29, 26
▲ Buy · 🎯$15
Price at call : $10.94 — upside +37%
Today : $8.41 — upside +78%
Expected +37% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on CERT : 50% (2 calls matureds) · 📊 on Health : 50% · +2.7% (74 calls)
-26.2%
stock -26% · XLV +29%
matured Aug 7, 26
▲ Overweight · 🎯$15
Price at call : $11.14 — upside +35%
Today : $8.41 — upside +78%
Expected +35% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on CERT : 0% (4 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
-40.1%
stock -40% · XLV +17%
matured Jul 14, 26
▲ Overweight · 🎯$14
Price at call : $11.98 — upside +17%
Today : $8.41 — upside +66%
Expected +17% · Actual -57% · Reason (≥ +15%) : ✗ No
🎯 on CERT : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
-57.2%
stock -57% · XLV +8%
matured May 8, 26
JMP Securities
May 6, 25
■ Market Perform neutral · not a buy
🎯 on CERT : no call matured yet · 📊 unranked overall
in progress (365j)
matures : May 6, 26
matures : May 6, 26
▲ Overweight · 🎯$18
Price at call : $13.53 — upside +33%
Today : $8.41 — upside +114%
Expected +33% · Actual -54% · Reason (≥ +15%) : ✗ No
🎯 on CERT : 0% (4 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
-54.5%
stock -54% · XLV +8%
matured Apr 16, 26
■ Neutral neutral · not a buy · 🎯$13
Price at call : $12.91 — gap to target +1%
Today : $8.41 — gap to target +55%
🎯 on CERT : no call matured yet · 📊 on Health : 37.8% · -2.8% (82 calls)
in progress (365j)
matures : Apr 11, 26
matures : Apr 11, 26
■ Equal-Weight neutral · not a buy · 🎯$11
Price at call : $12.91 — gap to target -15%
Today : $8.41 — gap to target +31%
🎯 on CERT : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Apr 10, 26
matures : Apr 10, 26
■ Equal-Weight neutral · not a buy · 🎯$13
Price at call : $11.94 — gap to target +9%
Today : $8.41 — gap to target +55%
🎯 on CERT : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Feb 28, 26
matures : Feb 28, 26
Stephens & Co. ↗
Feb 27, 25
▲ Overweight · 🎯$17
Price at call : $11.98 — upside +42%
Today : $8.41 — upside +102%
Expected +42% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on CERT : 0% (2 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
-41.1%
stock -41% · XLV +6%
matured Feb 27, 26
■ Equal-Weight neutral · not a buy · 🎯$12
Price at call : $11.03 — gap to target +9%
Today : $8.41 — gap to target +43%
🎯 on CERT : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Nov 7, 25
matures : Nov 7, 25
■ Neutral neutral · not a buy · 🎯$13
Price at call : $10.31 — gap to target +26%
Today : $8.41 — gap to target +55%
🎯 on CERT : no call matured yet · 📊 on Health : 37.8% · -2.8% (82 calls)
in progress (365j)
matures : Nov 5, 25
matures : Nov 5, 25
■ Equal-Weight neutral · not a buy · 🎯$14
Price at call : $11.22 — gap to target +25%
Today : $8.41 — gap to target +66%
🎯 on CERT : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Oct 15, 25
matures : Oct 15, 25
▲ Buy · 🎯$16
Price at call : $11.71 — upside +37%
Today : $8.41 — upside +90%
Expected +37% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on CERT : 50% (2 calls matureds) · 📊 on Health : 50% · +2.7% (74 calls)
+4.0%
stock +4% · XLV -12%
matured Sep 27, 25
■ Neutral neutral · not a buy · 🎯$16
Price at call : $13.07 — gap to target +22%
Today : $8.41 — gap to target +90%
🎯 on CERT : 50% (2 calls matureds) · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : Aug 7, 25
matures : Aug 7, 25
■ Neutral neutral · not a buy · 🎯$18
Price at call : $13.07 — gap to target +38%
Today : $8.41 — gap to target +114%
🎯 on CERT : no call matured yet · 📊 on Health : 37.8% · -2.8% (82 calls)
in progress (365j)
matures : Aug 7, 25
matures : Aug 7, 25
▲ Overweight · 🎯$20
Price at call : $15.12 — upside +32%
Today : $8.41 — upside +138%
Expected +32% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on CERT : 0% (4 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
-26.7%
stock -27% · XLV -8%
matured Jul 11, 25
JMP Securities
Jul 10, 24
■ Market Perform neutral · not a buy
🎯 on CERT : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Jul 10, 25
matures : Jul 10, 25
■ Equal-Weight neutral · not a buy · 🎯$16
Price at call : $13.64 — gap to target +17%
Today : $8.41 — gap to target +90%
🎯 on CERT : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Jun 28, 25
matures : Jun 28, 25
▲ Overweight · 🎯$23
Price at call : $18.46 — upside +25%
Today : $8.41 — upside +173%
Expected +25% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on CERT : 0% (4 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
-43.1%
stock -43% · XLV -5%
matured Apr 10, 25
JMP Securities
Apr 4, 24
■ Market Perform neutral · not a buy
🎯 on CERT : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Apr 4, 25
matures : Apr 4, 25
■ Neutral neutral · not a buy · 🎯$20
Price at call : $18.88 — gap to target +6%
Today : $8.41 — gap to target +138%
🎯 on CERT : 50% (2 calls matureds) · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : Mar 1, 25
matures : Mar 1, 25
■ Hold neutral · not a buy · 🎯$15.5
Price at call : $18.3 — gap to target -15%
Today : $8.41 — gap to target +84%
🎯 on CERT : no call matured yet · 📊 on Health : 50% · +9.9% (136 calls)
in progress (365j)
matures : Mar 1, 25
matures : Mar 1, 25
Leerink Partners ↗
Feb 26, 24
■ Market Perform neutral · not a buy · 🎯$19
Price at call : $16.86 — gap to target +13%
Today : $8.41 — gap to target +126%
🎯 on CERT : no call matured yet · 📊 on Health : 50% · -5.3% (10 calls)
in progress (365j)
matures : Feb 25, 25
matures : Feb 25, 25
■ Equal-Weight neutral · not a buy · 🎯$18
Price at call : $16.62 — gap to target +8%
Today : $8.41 — gap to target +114%
🎯 on CERT : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Jan 24, 25
matures : Jan 24, 25
■ Neutral neutral · not a buy · 🎯$17
Price at call : $16.1 — gap to target +6%
Today : $8.41 — gap to target +102%
🎯 on CERT : 50% (2 calls matureds) · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : Dec 6, 24
matures : Dec 6, 24
■ Sector Weight neutral · not a buy
🎯 on CERT : 0% (4 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : Dec 4, 24
matures : Dec 4, 24
Stephens & Co. ↗
Oct 11, 23
▲ Overweight · 🎯$20
Price at call : $14.28 — upside +40%
Today : $8.41 — upside +138%
Expected +40% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on CERT : 0% (2 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
-18.9%
stock -19% · XLV +17%
matured Oct 10, 24
■ Hold neutral · not a buy · 🎯$17
Price at call : $15.67 — gap to target +8%
Today : $8.41 — gap to target +102%
🎯 on CERT : no call matured yet · 📊 on Health : 50% · +9.9% (136 calls)
in progress (365j)
matures : Aug 21, 24
matures : Aug 21, 24
B of A Securities ↗
Aug 15, 23
▲ Buy · 🎯$24
Price at call : $16.9 — upside +42%
Today : $8.41 — upside +185%
Expected +42% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on CERT : 0% (1 call matured) · 📊 on Health : 51.3% · +3.0% (152 calls)
-30.1%
stock -30% · XLV +12%
matured Aug 14, 24
Frequently asked questions
Should I buy Certara, Inc. stock?
This isn't buy advice. For Certara, Inc., the analyst consensus is "Hold", with an average price target of $8.00 (-5% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 50% of the time (2 calls tracked on Certara, Inc.). We show the numbers — you decide.
Is it too late to buy Certara, Inc.? How high can it go?
The most bullish analyst target on Certara, Inc. is $10.00 (+19% above today's price); the average is $8.00. That's the upside they see. Check how reliable those analysts have actually been on Certara, Inc. on our site before trusting it.
Is Certara, Inc. still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 8 analysts have a real record on Certara, Inc., the best hitting 50% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.
Will Certara, Inc. stock recover (go back up)?
It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will CERT stock recover (go back up)?
Should you invest in Certara, Inc.? The case for and against
The arguments for and against, one by one, from the numbers: why invest in CERT (and why hesitate).
What has Certara, Inc.'s past performance been?
Historical returns and a "how much if I had invested" calculator: CERT performance & returns.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX